Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Attention-deficit hyperactivity disorder (ADHD) is a common condition during childhood that is associated with significant psychosocial dysfunction. Psychostimulants are the compounds that have been most extensively studied for the treatment of ADHD in children. There is substantial scientific evidence that several methylphenidate- and amphetamine-based preparations have acute efficacy in the treatment of this condition in children. The short-term safety and tolerability of these compounds has been reasonably well-studied and the risks associated with psychostimulant therapy in the short-term are generally acceptable. However, the amount of long-term effectiveness and safety data relating to these compounds is relatively small. Data that do exist suggest that long-term treatment with psychostimulants in appropriately diagnosed patients may be associated with salutary effects as well as relatively modest risks. Until more extensive, methodologically rigorous data are available, it appears that judicious psychostimulant pharmacotherapy of ADHD in children may be justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Treatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., Atkins, M., McBurnett, K., Bukstein, O., August, G., et al. (2001) · Pediatrics · doi:10.1542/peds.108.4.883 · Cited by 502
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
Gillberg, C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210105014 · Cited by 340
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003) · Pediatrics · doi:10.1542/peds.111.1.97 · Cited by 274
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
SPENCER, T. J., BIEDERMAN, J., HARDING, M., O'DONNELL, D., FARAONE, S. V., & WILENS, T. E. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00014 · Cited by 238 · cited 1×
“Spencer (1996) [45] Observational, historical NA 233 ADHD (with and without treatment with any drug or psychostimulant) versus non-ADHD controls Decreased growth rate ADHD patients had slight but statistically significant slower growth rate early in adolescence but this difference is not noted in late adolescence”
BackgroundBiederman, J., Lopez, F. A., Boellner, S. W., & Chandler, M. C. (2002) · Pediatrics · doi:10.1542/peds.110.2.258 · Cited by 180
WILENS, T., PELHAM, W., STEIN, M., CONNERS, C. K., ABIKOFF, H., ATKINS, M., AUGUST, G., GREENHILL, L., MCBURNETT, K., PALUMBO, D., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046814.95464.7d · Cited by 148
Biederman, J., Faraone, S. V., Monuteaux, M. C., Plunkett, E. A., Gifford, J., & Spencer, T. (2003) · Pediatrics · doi:10.1542/peds.111.5.1010 · Cited by 133
Cited by
Lambez, B., Harwood-Gross, A., Golumbic, E. Z., & Rassovsky, Y. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.007 · Cited by 207
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185
Gau, S. S. F., Shen, H.-Y., Chou, M.-C., Tang, C.-S., Chiu, Y.-N., & Gau, C.-S. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.286 · Cited by 148
Mannuzza, S., Klein, R. G., & Moulton, J. L. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322572606 · Cited by 83
Metadata
- Authors
- Kociancic, T., Reed, M. D., & Findling, R. L.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2004-03
- Volume
- 3
- Issue
- 2
- Pages
- 93-100
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2145077756
- Cited by
- 22
- References
- 13
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. https://app.cochat.ai/papers/10.1517/14740338.3.2.93
- The paper
- Kociancic, T., Reed, M. D., & Findling, R. L. (2004). Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.3.2.93
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.